/PRNewswire/ Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the closing of a.
/PRNewswire/ Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the closing of a.
Global leader brings 30+ years of biopharma experience to Axogen, Inc. Board of Directors
ALACHUA, Fla. and TAMPA, Fla., July 19, 2021 (GLOBE NEWSWIRE) Axogen, Inc. ( AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that John H. Johnson has been appointed to its Board of Directors, effective July 19, 2021. Johnson will serve on both the Governance, Nominating and Sustainability Committee and the Science and Technology Committee. Johnson is a recognized leader in the biopharmaceutical industry with more than 30 years of experience in senior leadership positions, including at Johnson & Johnson, Eli Lilly & Company, ImClone, and Centocor Ortho Biotech.
Axogen, Inc Appoints John H Johnson to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.